Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc | 82 000 | déclaré | 17 sept. 2019 | tx 8+334 834−113 442 |
| Viridian Therapeutics, Inc.\DE | 33 349 | déclaré | 03 mars 2026 | tx 10+2 484 650−33 392 |
| Dianthus Therapeutics, Inc. /DE/ | 17 264 | déclaré | 30 nov. 2022 | tx 7+780 500−5 736 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 03 mars 2026 | TAX_WITHHOLDING | Viridian Therapeutics, Inc.\DE | 7 627 | 29.32 USD | |
| 03 mars 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 18 357 | — | |
| 02 mars 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 111 900 | 0.00 USD | deriv |
| 02 mars 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 559 600 | 0.00 USD | deriv |
| 03 mars 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 18 357 | 0.00 USD | deriv |
| 03 mars 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 73 428 | 0.00 USD | deriv |
| 03 mars 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 440 565 | 0.00 USD | deriv |
| 27 sept. 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 21 400 | 23.33 USD | 1er après silence |
| 30 oct. 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 1 259 400 | 0.00 USD | deriv |
| 30 nov. 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3 000 | 0.94 USD | |
| 01 août 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 130 000 | 0.00 USD | deriv |
| 17 mai 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 62 500 | 0.00 USD | deriv |
| 15 févr. 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 130 000 | 0.00 USD | deriv |
| 16 sept. 2021 | SALE | Dianthus Therapeutics, Inc. /DE/ | 5 736 | 6.73 USD | |
| 14 sept. 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 20 000 | 0.00 USD | |
| 02 nov. 2020 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 435 000 | 0.00 USD | deriv |
| 17 sept. 2019 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 82 000 | 0.00 USD | deriv |
| 04 mars 2019 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 83 000 | 0.00 USD | deriv |
| 20 sept. 2018 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 50 000 | 0.00 USD | deriv |
| 29 mai 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 6 392 | 0.00 USD | |
| 29 mai 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 107 050 | 0.00 USD | deriv |
| 29 mai 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 6 392 | 0.00 USD | deriv |
| 29 mai 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 107 050 | 0.00 USD | deriv |
| 09 févr. 2018 | PURCHASE | Kiniksa Pharmaceuticals International, plc | 6 392 | 15.64 USD | deriv |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 27 sept. 2024.